go back

Prostate Cancer Urine And PSA Risk Test

Vermont rates for HCPCS 0113U

Estimates the risk that a man has prostate cancer, to help decide whether a biopsy is warranted. It measures two RNA markers in urine, PCA3 and the TMPRSS2-ERG fusion, and combines them with the PSA protein level from blood into a single risk score.

Rates data updated June 2026.

Facilitymedian $759 · 10th–90th $759$1,2590%20%40%90th$759Professionalmedian $759 · 10th–90th $537$9330%20%40%10th90th$759$500.0$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$537.03
Median
$537.03
Typical High
$933.25
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,258.93
Median
$1,258.93
Typical High
$1,258.93
Cigna
Setting
Professional
Modifier
Global
Typical Low
$758.58
Median
$758.58
Typical High
$758.58
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$758.58
Median
$758.58
Typical High
$758.58
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$758.58
Median
$758.58
Typical High
$758.58
United
Setting
Professional
Modifier
Global
Typical Low
$346.74
Median
$758.58
Typical High
$3,388.44